Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gynecologic 78Breast 12Gastrointestinal 11Thoracic 9Sarcoma 9Genitourinary 6Dermatologic 6Head & Neck 5Other hematologic neoplasm 4Lymphoid 4Other solid neoplasm 3CNS 3Plasma cell 2Classical hematology 2Other 1NET 1Myeloid 1Endocrine 1

Conditions

Neoplasms 68Venous Thromboembolism 60Anemia 33Leukemia, Myeloid, Acute 28Anemia, Sickle Cell 26Multiple Myeloma 25Hematologic Neoplasms 25Myelodysplastic Syndromes 24Febrile Neutropenia 24Leukemia 22Lymphoma 19Anemia, Aplastic 19Thrombocytopenia 17Myeloproliferative Disorders 16Breast Neoplasms 16Anemia, Refractory, with Excess of Blasts 16Neutropenia 14Venous Thrombosis 13Lymphoma, Non-Hodgkin 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 12Lung Neoplasms 12Hodgkin Disease 12Fanconi Anemia 12Colorectal Neoplasms 12Ovarian Neoplasms 11Leukemia, Lymphocytic, Chronic, B-Cell 10Thrombosis 9Pulmonary Embolism 9Pancreatic Neoplasms 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Fallopian Tube Neoplasms × Classical hematology × Clear all
NCT06483997 2026-01-29

Diet, Hepcidin, and Chemotherapy RDI

George Washington University

Active not recruiting
100 enrolled
Classical hematologyGynecologic

Anemia, Fallopian Tube Neoplasms, Inflammation, Ovarian Neoplasms, Endometrial Neoplasms

NCT02503436 2023-12-04

C-PATROL

AstraZeneca

Completed
276 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡